Let's Talk Micro

• 207: Micro Lab and Stewardship: Collaboration in Action (Pt.2)

  In this second half of our discussion with Dr. Erin McCreary and Dr. Hannah Creager, we dive deeper into how microbiology and antimicrobial stewardship teams collaborate to improve patient outcomes. They unpack how to prioritize breakpoint updates, the pros and cons of cascade reporting, and what nudges can do to guide better prescribing. Then we explore a powerful example of collaboration—the transition from MRSA agar to PCR across hospitals—and what it taught both teams about communication, resource sharing, and patient safety. Finally, Erin and Hannah reflect on lessons learned, first steps for building collaboration, and even share their favorite microbes (spoiler: both picked viruses!). 🎧 Tune in to learn how intentional teamwork between the lab and stewardship can transform patient care and lab efficiency.   Stay connected with Let’s Talk Micro: Website: letstalkmicro.com Questions or feedback? Email me at [email protected] Support the podcast: Venmo Buy me a Ko-fi  

  --------  

  40:35

  --------

  40:35
• 206: Micro Lab and Stewardship: Collaboration in Action (Pt.1)

  Good communication isn’t optional—it’s essential for patient care. In Part 1 of this two-part series, Dr. Erin McCreary and Dr. Hannah Creager join Luis to talk about how microbiology labs and antimicrobial stewardship teams can collaborate more effectively. They share real-world examples from their system-wide work—aligning AST panels and breakpoints across multiple platforms, navigating reporting challenges like the clindamycin D-test and rifampin comments, and building consistent communication through monthly micro–stewardship meetings. It’s a behind-the-scenes look at how strong collaboration turns into better patient outcomes.   Stay connected with Let’s Talk Micro: Website: letstalkmicro.com Questions or feedback? Email me at [email protected] Support the podcast: Venmo Buy me a Ko-fi  

  --------  

  44:49

  --------

  44:49
• 205: Complicated UTIs: The New IDSA Guidelines

  The Infectious Diseases Society of America (IDSA) has released new guidelines for the treatment of complicated urinary tract infections. In this episode, we break down the key updates: Changes to the definition of complicated UTIs The role of newer antibiotic agents How and when to use antibiograms A four-step framework for guiding therapy When carbapenems are necessary—and when other options may be just as effective Shorter durations of therapy Join Dr. Barbara Trautner, Dr. Nicolas Cortés-Penfield, and Dr. Kalpana Gupta as they discuss what these guidelines mean for clinicians, microbiologists, and patients. 👉 Stay tuned until the end for a special announcement.   Resources from this episode: 2025 cUTI IDSA guidelines   Stay connected with Let’s Talk Micro: Website: letstalkmicro.com Questions or feedback? Email me at [email protected] Support the podcast: Venmo Buy me a Ko-fi  

  --------  

  38:24

  --------

  38:24
• 204: In the Bloodstream: Diagnosing Infections Faster

  Bloodstream infections can progress rapidly to sepsis—bringing high costs, high mortality, and lasting effects. In the second episode of this series in collaboration with bioMérieux, Luis speaks with Dr. Jeff Cies, Senior Medical Advisor at bioMérieux, about how molecular diagnostics are reshaping bloodstream infection diagnosis. They discuss: Limitations of traditional blood cultures How rapid molecular tests deliver results faster than ever The impact on outcomes, costs, and antimicrobial resistance The role of stewardship programs in maximizing results What the future holds: direct-from-blood testing, nanotechnology, and AI A powerful look at how innovation in microbiology is changing the fight against sepsis and saving lives. This episode is sponsored by bioMérieux, a global innovator in infectious disease diagnostics. Resources from this episode: bioMérieux Sepsis Webinar Stay connected with Let’s Talk Micro: Website: letstalkmicro.com Questions or feedback? Email me at [email protected] Support the podcast: Venmo Buy me a Ko-fi  

  --------  

  35:35

  --------

  35:35
• 203: What’s New with Brucella?

  Brucella is a familiar name in the lab—but recent updates to the sentinel guidelines are reshaping how we approach this pathogen. In this episode, I’m joined by Dr. Laura Filkins and Dr. Paige Larkin to discuss the latest changes: updates in nomenclature, the removal of certain Brucella species from the select agent list, and the renewed emphasis on safety in the lab. We dive into taxonomy controversies, clinical features of brucellosis, and practical steps laboratorians can take to protect themselves while delivering accurate results. Whether you’re a student, laboratorian, or clinician, this conversation highlights what you need to know about the evolving landscape of Brucella diagnostics and safety.   Resources from this episode: CDC’s Brucellosis Information Page ASM Updates on Brucella Stay connected with Let’s Talk Micro: Website: letstalkmicro.com Questions or feedback? Email me at [email protected] Support the podcast: Venmo Buy me a Ko-fi  

  --------  

  44:44

  --------

  44:44

Mais podcasts de Ciência

Podcasts em tendência em Ciência

Sobre Let's Talk Micro